395 Trademark Results found for "*NOR"

Also try searching for:

NOR*

Details	Status	Class/Description
CORLANOR BIOFARMA SOCIÉTÉ PAR ACTIONS SIMPLIFIÉE 1450964 8 Sept 2009	ABANDONED SECTION 40(3) on 26 Sept 2012	Préparations pharmaceutiques pour le traitement des maladies cardiovas... Class 005 Class 005 Pharmaceutical Products Préparations pharmaceutiques pour le traitement des maladies cardiovasculaires.
GENOR GENOR BIOPHARMA CO. LTD. 1444812 15 Jul 2009	REGISTERED on 28 Feb 2013	Pharmaceutical advice.,Treatment of materials for the manufacturing of... Class 001 Class 001 Chemical Products Class 005 Class 005 Pharmaceutical Products Biological preparations for pharmaceutical purposes for the treatment of hepatitis A, inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, blood disorders, nutritional disorders, namely, mineral deficiency and toxicity, obesity, metabolic syndrome, under nutrition, vitamin deficiency, dependency and toxicity, immunological diseases, namely, autoimmune diseases, immunologic deficiency syndromes, dermatological disorders, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, genetic disorders, namely, lysosomal storage diseases, mucopolysaccharidoses, phenylketonuria, alpha-mannosidosis, cystic fibrosis and muscular dystrophy, neurodegenerative diseases, namely, anxiety, depression, sleep disorders, chronic fatigue, schizophrenia, epilepsy, viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), and infectious diseases, namely, respiratory infections, eye infections, antiparasites, cancer, obesity and diabetes in humans; sanitary preparations for medical use in the treatment of hepatitis A, inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, blood disorders, nutritional disorders, namely, mineral deficiency and toxicity, obesity, metabolic syndrome, under nutrition, vitamin deficiency, dependency and toxicity, immunological diseases, namely, autoimmune diseases, immunologic deficiency syndromes, dermatological disorders, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, genetic disorders, namely, lysosomal storage diseases, mucopolysaccharidoses, phenylketonuria, alpha-mannosidosis, cystic fibrosis and muscular dystrophy, neurodegenerative diseases, namely, anxiety, depression, sleep disorders, chronic fatigue, schizophrenia, epilepsy, viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), and infectious diseases, namely, respiratory infections, eye infections, antiparasites, cancer, obesity and diabetes in humans; medicines for treatment of viral and bacterial infections, namely, hepatitis A, inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, blood disorders, nutritional disorders, namely, mineral deficiency and toxicity, obesity, metabolic syndrome, under nutrition, vitamin deficiency, dependency and toxicity, immunological diseases, namely, autoimmune diseases, immunologic deficiency syndromes, dermatological disorders, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, genetic disorders, namely, lysosomal storage diseases, mucopolysaccharidoses, phenylketonuria, alpha-mannosidosis, cystic fibrosis and muscular dystrophy, neurodegenerative diseases, namely, anxiety, depression, sleep disorders, chronic fatigue, schizophrenia, epilepsy, viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), and infectious diseases, namely, respiratory infections, eye infections, antiparasites, cancer, obesity and diabetes in humans; active pharmaceutical ingredients for the treatment of viral and bacterial infections, namely, hepatitis A, inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, blood disorders, nutritional disorders, namely, mineral deficiency and toxicity, obesity, metabolic syndrome, under nutrition, vitamin deficiency, dependency and toxicity, immunological diseases, namely, autoimmune diseases, immunologic deficiency syndromes, dermatological disorders, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, genetic disorders, namely, lysosomal storage diseases, mucopolysaccharidoses, phenylketonuria, alpha-mannosidosis, cystic fibrosis and muscular dystrophy, neurodegenerative diseases, namely, anxiety, depression, sleep disorders, chronic fatigue, schizophrenia, epilepsy, viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), and infectious diseases, namely, respiratory infections, eye infections, antiparasites, cancer, obesity and diabetes in humans; biological substances and preparations for medical use and purposed for the treatment of viral and bacterial infections, namely, hepatitis A, inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, blood disorders, nutritional disorders, namely, mineral deficiency and toxicity, obesity, metabolic syndrome, under nutrition, vitamin deficiency, dependency and toxicity, immunological diseases, namely, autoimmune diseases, immunologic deficiency syndromes, dermatological disorders, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, genetic disorders, namely, lysosomal storage diseases, mucopolysaccharidoses, phenylketonuria, alpha-mannosidosis, cystic fibrosis and muscular dystrophy, neurodegenerative diseases, namely, anxiety, depression, sleep disorders, chronic fatigue, schizophrenia, epilepsy, viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), and infectious diseases, namely, respiratory infections, eye infections, antiparasites, cancer, obesity and diabetes in humans; human vaccines; monoclonal antibodies; recombinant pharmaceuticals for the treatment of viral and bacterial infections, namely, hepatitis A, inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, blood disorders, nutritional disorders, namely, mineral deficiency and toxicity, obesity, metabolic syndrome, under nutrition, vitamin deficiency, dependency and toxicity, immunological diseases, namely, autoimmune diseases, immunologic deficiency syndromes, dermatological disorders, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, genetic disorders, namely, lysosomal storage diseases, mucopolysaccharidoses, phenylketonuria, alpha-mannosidosis, cystic fibrosis and muscular dystrophy, neurodegenerative diseases, namely, anxiety, depression, sleep disorders, chronic fatigue, schizophrenia, epilepsy, viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), and infectious diseases, namely, respiratory infections, eye infections, antiparasites, cancer, obesity and diabetes in humans; protein for use as an additive for medical/pharmaceutical preparations for human consumption [adapted for medical purposes] for the treatment of viral and bacterial infections, namely, hepatitis A, inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, blood disorders, nutritional disorders, namely, mineral deficiency and toxicity, obesity, metabolic syndrome, under nutrition, vitamin deficiency, dependency and toxicity, immunological diseases, namely, autoimmune diseases, immunologic deficiency syndromes, dermatological disorders, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, genetic disorders, namely, lysosomal storage diseases, mucopolysaccharidoses, phenylketonuria, alpha-mannosidosis, cystic fibrosis and muscular dystrophy, neurodegenerative diseases, namely, anxiety, depression, sleep disorders, chronic fatigue, schizophrenia, epilepsy, viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), and infectious diseases, namely, respiratory infections, eye infections, antiparasites, cancer, obesity and diabetes in humans; and biotechnological preparations for medical use for the treatment of viral and bacterial infections, namely, hepatitis A, inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, blood disorders, nutritional disorders, namely, mineral deficiency and toxicity, obesity, metabolic syndrome, under nutrition, vitamin deficiency, dependency and toxicity, immunological diseases, namely, autoimmune diseases, immunologic deficiency syndromes, dermatological disorders, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, genetic disorders, namely, lysosomal storage diseases, mucopolysaccharidoses, phenylketonuria, alpha-mannosidosis, cystic fibrosis and muscular dystrophy, neurodegenerative diseases, namely, anxiety, depression, sleep disorders, chronic fatigue, schizophrenia, epilepsy, viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), and infectious diseases, namely, respiratory infections, eye infections, antiparasites, cancer, obesity and diabetes in humans. ... Class 039 Transportation & Storage Services Transport and delivery of goods by air, truck, water. Class 040 Treatment & Processing of Materials Services Treatment of materials for the manufacturing of biotechnological pharmaceuticals and pharmaceuticals. Class 044 Medical, Beauty & Agricultural Services Pharmaceutical advice.
DAIRY MANOR LIDL STIFTUNG & CO. KG 1438049 13 May 2009	WITHDRAWN BY OWNER on 15 Apr 2010	Milk and dairy products, especially cheese, cheese products, butter; e... Class 029 Class 029 Meats and Processed Food Products Milk and dairy products, especially cheese, cheese products, butter; edible fats, margarine.
BALLY MANOR LIDL STIFTUNG & CO. KG 1426517 3 Feb 2009	REGISTERED on 23 Jul 2010	Fresh, preserved and/or frozen meat, fish, poultry and game; meat, fis... Class 029 Class 029 Meats and Processed Food Products Fresh, preserved and/or frozen meat, fish, poultry and game; meat, fish, poultry and game products; meat, fish, poultry and game preserves; ready-to-serve meals essentially consisting of the aforementioned goods.
P.W. MINOR SAN ANTONIO SHOE INC. 1425555 26 Jan 2009	REGISTERED on 28 Jun 2010	Athletic shoes; boots; leather shoes; leisure shoes; shoes; women's sh... Class 025 Class 025 Clothing Products Athletic shoes; boots; leather shoes; leisure shoes; shoes; women's shoes; work shoes and boots.
P.W. MINOR P.W. MINOR AND SON INC. 1425114 21 Jan 2009	WITHDRAWN BY OWNER on 9 Mar 2009	Athletic shoes; boots; leather shoes; leisure shoes; shoes; women's sh... Class 025 Class 025 Clothing Products Athletic shoes; boots; leather shoes; leisure shoes; shoes; women's shoes; work shoes and boots.
MOLYNOR MOLIBDENOS Y METALES S.A. 1423370 31 Dec 2008	ABANDONED SECTION 40(3) on 23 Jan 2013	Chemicals to be used in agricultural, mining, oil refinery and foodstu... Class 001 Class 001 Chemical Products Class 006 Class 006 Metal Products ... Class 014 Jewelry Products Class 019 Non-Metallic Building Material Products Chemicals to be used in agricultural, mining, oil refinery and foodstuff for animals industries; unprocessed artificial resins to be used in industry, science and agriculture; adhesives for industry for covering and sealing; land manure; chemical products for preserving food; chemical products from molybdenum oxide for making molybdenum salts, chemical and petrochemical industry catalysts and metallic molybdenum, namely chemical additives for plastics, for catalysts, for inhibiting corrosion, for paintings, for surface coverings, for ceramics and for micronutrients of plants and animals; chemical products from molybdenum salts for making pure molybdenum oxide, metallic molybdenum and catalysts for the chemical and agriculture industry, namely chemical additives for plastics, for catalysts, for inhibiting corrosion, for paintings, for surface coverings, for ceramics and for micronutrients of plants and animals; chemical products of rhenium for making rhenium salts, catalysts to be used in the chemical industry and the making of metallic rhenium and perrhenic acid, namely chemical additives for plastics, for catalysts, for inhibiting corrosion, for paintings, for surface coverings, for ceramics and for micronutrients of plants and animals; chemical products from tungsten for making metallic tungsten, tungsten carbide and catalysts for chemical industry, namely chemical additives for plastics, for catalysts, for inhibiting corrosion, for paintings, for surface coverings, for ceramics and for micronutrients of plants and animals; chemical products from tantalum for making metallic tantalum and tantalum alloys, namely chemical additives for plastics, for catalysts, for inhibiting corrosion, for paintings, for surface coverings, for ceramics and for micronutrients of plants and animals; chemical products from niobium for making metallic niobium and alloys, namely chemical additives for plastics, for catalysts, for inhibiting corrosion, for paintings, for surface coverings, for ceramics and for micronutrients of plants and animals; chemical products from cobalt to be used in the chemical industry as a pigment, in the metallurgic industry for the making of alloys and superalloys, for the making of salts to be used in the electrodeposition of metals; sulfuric acid, calcium carbide, copper oxides, copper salts, namely chemical additives for plastics, for catalysts, for inhibiting corrosion, for paintings, for surface coverings, for ceramics and for micronutrients of plants and animals; chemical products of copper to be used in the manufacture of fungicides for use in the agriculture industry, in the manufacture of alimentary complements for use in the chicken and pigs breeding industry, for electrodeposition of copper and making of alloys in the metallurgic industry; non-metallic minerals, namely, quartz, feldspars, clays, all for using in the chemical and metallurgic industry, namely chemical additives for plastics, for catalysts, for inhibiting corrosion, for paintings, for surface coverings, for ceramics and for micronutrients of plants and animals; common metals and their alloys for further manufacture; metallic construction materials, namely, panels, laminations, pipes, cables and filaments; molybdenum minerals and their alloys; rhenium minerals and their alloys; metallic materials for electric resistances of boilers; high temperature mechanically resistant trays, namely, metal molds for casting ceramic materials, foundry chill-molds, or metal moldings; metal corrosion resistant pipes and valves; copper minerals and their alloys; tungsten minerals and their alloys; tantalum minerals and their alloys; niobium minerals and their alloys; cobalt minerals and their alloys; metallic products, namely, corrosion resistant laminations, sheets and pipes; precious metals and their alloys; products elaborated from precious metals, namely, jewelry.
METANOR MEDA AB 1410973 16 Sept 2008	ABANDONED SECTION 40(3) on 9 Oct 2013	Pharmaceutical preparations, namely analgesics. Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations, namely analgesics.
TOVANOR Novartis AG 1398299 5 Jun 2008	ABANDONED SECTION 40(3) on 25 Jun 2014	Pharmaceutical preparations for the prevention and treatment of the ce... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the prevention and treatment of the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and treatment of immunologic diseases, namely autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely diabetes, obesity, hyperlipidemia, insulin resistance; anti-inflammatories; pharmaceutical preparations for the prevention and treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and treatment of disorders of the musculo-skeletal system, namely connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains and cartilage injuries; pharmaceutical preparations for the prevention and treatment of disorders of the genitourinary system, namely urological diseases, infertility, sexually transmitted diseases and inflammatory pelvic diseases; pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases and sexually transmitted diseases; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in hematology; pharmaceutical preparations for use in preventing rejection of transplanted organs; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for use in the gastroenterological area and the prevention and treatment of ocular disorders or diseases; anti-infectives; anti-bacterials; antivirals; anti-biotics; anti-fungals.
MANOIR LAKESHORE MANOR JACQUELINE VAUGHAN 1372911 20 Nov 2007	REGISTERED on 20 Jul 2010	Accommodation packages for various lengths of extended stays, accommod... Class 043 Class 043 Restaurant and Hotel Services Accommodation packages for various lengths of extended stays, accommodation suites include housekeeping services, kitchenette and private bathrooms, parking spaces for clients; provision of corporate executive/tourist stay accommodation rooms.

ABANDONED SECTION 40(3)

on 26 Sept 2012

CORLANOR

BIOFARMA SOCIÉTÉ PAR ACTIONS SIMPLIFIÉE

1450964 · 8 Sept 2009

005

Préparations pharmaceutiques pour le traitement des maladies cardiovas...

REGISTERED

on 28 Feb 2013

GENOR

GENOR BIOPHARMA CO. LTD.

1444812 · 15 Jul 2009

001

005

Class 005

Pharmaceutical Products

Biological preparations for pharmaceutical purposes for the treatment of hepatitis A, inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, blood disorders, nutritional disorders, namely, mineral deficiency and toxicity, obesity, metabolic syndrome, under nutrition, vitamin deficiency, dependency and toxicity, immunological diseases, namely, autoimmune diseases, immunologic deficiency syndromes, dermatological disorders, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, genetic disorders, namely, lysosomal storage diseases, mucopolysaccharidoses, phenylketonuria, alpha-mannosidosis, cystic fibrosis and muscular dystrophy, neurodegenerative diseases, namely, anxiety, depression, sleep disorders, chronic fatigue, schizophrenia, epilepsy, viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), and infectious diseases, namely, respiratory infections, eye infections, antiparasites, cancer, obesity and diabetes in humans; sanitary preparations for medical use in the treatment of hepatitis A, inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, blood disorders, nutritional disorders, namely, mineral deficiency and toxicity, obesity, metabolic syndrome, under nutrition, vitamin deficiency, dependency and toxicity, immunological diseases, namely, autoimmune diseases, immunologic deficiency syndromes, dermatological disorders, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, genetic disorders, namely, lysosomal storage diseases, mucopolysaccharidoses, phenylketonuria, alpha-mannosidosis, cystic fibrosis and muscular dystrophy, neurodegenerative diseases, namely, anxiety, depression, sleep disorders, chronic fatigue, schizophrenia, epilepsy, viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), and infectious diseases, namely, respiratory infections, eye infections, antiparasites, cancer, obesity and diabetes in humans; medicines for treatment of viral and bacterial infections, namely, hepatitis A, inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, blood disorders, nutritional disorders, namely, mineral deficiency and toxicity, obesity, metabolic syndrome, under nutrition, vitamin deficiency, dependency and toxicity, immunological diseases, namely, autoimmune diseases, immunologic deficiency syndromes, dermatological disorders, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, genetic disorders, namely, lysosomal storage diseases, mucopolysaccharidoses, phenylketonuria, alpha-mannosidosis, cystic fibrosis and muscular dystrophy, neurodegenerative diseases, namely, anxiety, depression, sleep disorders, chronic fatigue, schizophrenia, epilepsy, viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), and infectious diseases, namely, respiratory infections, eye infections, antiparasites, cancer, obesity and diabetes in humans; active pharmaceutical ingredients for the treatment of viral and bacterial infections, namely, hepatitis A, inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, blood disorders, nutritional disorders, namely, mineral deficiency and toxicity, obesity, metabolic syndrome, under nutrition, vitamin deficiency, dependency and toxicity, immunological diseases, namely, autoimmune diseases, immunologic deficiency syndromes, dermatological disorders, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, genetic disorders, namely, lysosomal storage diseases, mucopolysaccharidoses, phenylketonuria, alpha-mannosidosis, cystic fibrosis and muscular dystrophy, neurodegenerative diseases, namely, anxiety, depression, sleep disorders, chronic fatigue, schizophrenia, epilepsy, viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), and infectious diseases, namely, respiratory infections, eye infections, antiparasites, cancer, obesity and diabetes in humans; biological substances and preparations for medical use and purposed for the treatment of viral and bacterial infections, namely, hepatitis A, inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, blood disorders, nutritional disorders, namely, mineral deficiency and toxicity, obesity, metabolic syndrome, under nutrition, vitamin deficiency, dependency and toxicity, immunological diseases, namely, autoimmune diseases, immunologic deficiency syndromes, dermatological disorders, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, genetic disorders, namely, lysosomal storage diseases, mucopolysaccharidoses, phenylketonuria, alpha-mannosidosis, cystic fibrosis and muscular dystrophy, neurodegenerative diseases, namely, anxiety, depression, sleep disorders, chronic fatigue, schizophrenia, epilepsy, viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), and infectious diseases, namely, respiratory infections, eye infections, antiparasites, cancer, obesity and diabetes in humans; human vaccines; monoclonal antibodies; recombinant pharmaceuticals for the treatment of viral and bacterial infections, namely, hepatitis A, inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, blood disorders, nutritional disorders, namely, mineral deficiency and toxicity, obesity, metabolic syndrome, under nutrition, vitamin deficiency, dependency and toxicity, immunological diseases, namely, autoimmune diseases, immunologic deficiency syndromes, dermatological disorders, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, genetic disorders, namely, lysosomal storage diseases, mucopolysaccharidoses, phenylketonuria, alpha-mannosidosis, cystic fibrosis and muscular dystrophy, neurodegenerative diseases, namely, anxiety, depression, sleep disorders, chronic fatigue, schizophrenia, epilepsy, viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), and infectious diseases, namely, respiratory infections, eye infections, antiparasites, cancer, obesity and diabetes in humans; protein for use as an additive for medical/pharmaceutical preparations for human consumption [adapted for medical purposes] for the treatment of viral and bacterial infections, namely, hepatitis A, inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, blood disorders, nutritional disorders, namely, mineral deficiency and toxicity, obesity, metabolic syndrome, under nutrition, vitamin deficiency, dependency and toxicity, immunological diseases, namely, autoimmune diseases, immunologic deficiency syndromes, dermatological disorders, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, genetic disorders, namely, lysosomal storage diseases, mucopolysaccharidoses, phenylketonuria, alpha-mannosidosis, cystic fibrosis and muscular dystrophy, neurodegenerative diseases, namely, anxiety, depression, sleep disorders, chronic fatigue, schizophrenia, epilepsy, viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), and infectious diseases, namely, respiratory infections, eye infections, antiparasites, cancer, obesity and diabetes in humans; and biotechnological preparations for medical use for the treatment of viral and bacterial infections, namely, hepatitis A, inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, blood disorders, nutritional disorders, namely, mineral deficiency and toxicity, obesity, metabolic syndrome, under nutrition, vitamin deficiency, dependency and toxicity, immunological diseases, namely, autoimmune diseases, immunologic deficiency syndromes, dermatological disorders, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, genetic disorders, namely, lysosomal storage diseases, mucopolysaccharidoses, phenylketonuria, alpha-mannosidosis, cystic fibrosis and muscular dystrophy, neurodegenerative diseases, namely, anxiety, depression, sleep disorders, chronic fatigue, schizophrenia, epilepsy, viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), and infectious diseases, namely, respiratory infections, eye infections, antiparasites, cancer, obesity and diabetes in humans.

...

Pharmaceutical advice.,Treatment of materials for the manufacturing of...

WITHDRAWN BY OWNER

on 15 Apr 2010

DAIRY MANOR

LIDL STIFTUNG & CO. KG

1438049 · 13 May 2009

029

Milk and dairy products, especially cheese, cheese products, butter; e...

REGISTERED

on 23 Jul 2010

BALLY MANOR

LIDL STIFTUNG & CO. KG

1426517 · 3 Feb 2009

029

Fresh, preserved and/or frozen meat, fish, poultry and game; meat, fis...

REGISTERED

on 28 Jun 2010

P.W. MINOR

SAN ANTONIO SHOE INC.

1425555 · 26 Jan 2009

025

Athletic shoes; boots; leather shoes; leisure shoes; shoes; women's sh...

WITHDRAWN BY OWNER

on 9 Mar 2009

P.W. MINOR

P.W. MINOR AND SON INC.

1425114 · 21 Jan 2009

025

Athletic shoes; boots; leather shoes; leisure shoes; shoes; women's sh...

ABANDONED SECTION 40(3)

on 23 Jan 2013

MOLYNOR

MOLIBDENOS Y METALES S.A.

1423370 · 31 Dec 2008

001

006

...

Class 014

Jewelry Products

Class 019

Non-Metallic Building Material Products

Chemicals to be used in agricultural, mining, oil refinery and foodstuff for animals industries; unprocessed artificial resins to be used in industry, science and agriculture; adhesives for industry for covering and sealing; land manure; chemical products for preserving food; chemical products from molybdenum oxide for making molybdenum salts, chemical and petrochemical industry catalysts and metallic molybdenum, namely chemical additives for plastics, for catalysts, for inhibiting corrosion, for paintings, for surface coverings, for ceramics and for micronutrients of plants and animals; chemical products from molybdenum salts for making pure molybdenum oxide, metallic molybdenum and catalysts for the chemical and agriculture industry, namely chemical additives for plastics, for catalysts, for inhibiting corrosion, for paintings, for surface coverings, for ceramics and for micronutrients of plants and animals; chemical products of rhenium for making rhenium salts, catalysts to be used in the chemical industry and the making of metallic rhenium and perrhenic acid, namely chemical additives for plastics, for catalysts, for inhibiting corrosion, for paintings, for surface coverings, for ceramics and for micronutrients of plants and animals; chemical products from tungsten for making metallic tungsten, tungsten carbide and catalysts for chemical industry, namely chemical additives for plastics, for catalysts, for inhibiting corrosion, for paintings, for surface coverings, for ceramics and for micronutrients of plants and animals; chemical products from tantalum for making metallic tantalum and tantalum alloys, namely chemical additives for plastics, for catalysts, for inhibiting corrosion, for paintings, for surface coverings, for ceramics and for micronutrients of plants and animals; chemical products from niobium for making metallic niobium and alloys, namely chemical additives for plastics, for catalysts, for inhibiting corrosion, for paintings, for surface coverings, for ceramics and for micronutrients of plants and animals; chemical products from cobalt to be used in the chemical industry as a pigment, in the metallurgic industry for the making of alloys and superalloys, for the making of salts to be used in the electrodeposition of metals; sulfuric acid, calcium carbide, copper oxides, copper salts, namely chemical additives for plastics, for catalysts, for inhibiting corrosion, for paintings, for surface coverings, for ceramics and for micronutrients of plants and animals; chemical products of copper to be used in the manufacture of fungicides for use in the agriculture industry, in the manufacture of alimentary complements for use in the chicken and pigs breeding industry, for electrodeposition of copper and making of alloys in the metallurgic industry; non-metallic minerals, namely, quartz, feldspars, clays, all for using in the chemical and metallurgic industry, namely chemical additives for plastics, for catalysts, for inhibiting corrosion, for paintings, for surface coverings, for ceramics and for micronutrients of plants and animals; common metals and their alloys for further manufacture; metallic construction materials, namely, panels, laminations, pipes, cables and filaments; molybdenum minerals and their alloys; rhenium minerals and their alloys; metallic materials for electric resistances of boilers; high temperature mechanically resistant trays, namely, metal molds for casting ceramic materials, foundry chill-molds, or metal moldings; metal corrosion resistant pipes and valves; copper minerals and their alloys; tungsten minerals and their alloys; tantalum minerals and their alloys; niobium minerals and their alloys; cobalt minerals and their alloys; metallic products, namely, corrosion resistant laminations, sheets and pipes; precious metals and their alloys; products elaborated from precious metals, namely, jewelry.

Chemicals to be used in agricultural, mining, oil refinery and foodstu...

ABANDONED SECTION 40(3)

on 9 Oct 2013

METANOR

MEDA AB

1410973 · 16 Sept 2008

005

Pharmaceutical preparations, namely analgesics.

ABANDONED SECTION 40(3)

on 25 Jun 2014

TOVANOR

Novartis AG

1398299 · 5 Jun 2008

005

Pharmaceutical preparations for the prevention and treatment of the ce...

REGISTERED

on 20 Jul 2010

MANOIR LAKESHORE MANOR

JACQUELINE VAUGHAN

1372911 · 20 Nov 2007

043

Accommodation packages for various lengths of extended stays, accommod...

Owners

Honor device co. ltd. (6)

Melnor inc. (3)

Petronor inc. (3)

Arjo ip holding ab (2)

Astrazeneca ab (2)

Canadian standards association (2)

Dorinda medley, inc. (2)

Electronor corporation (2)

Fjordnor as (2)

Heel inc. (2)